Particle-Enhanced Turbidimetric Immunoassay Market
Particle-Enhanced Turbidimetric Immunoassay Market Study by Application for Infectious Diseases, Endocrinology, Cardiology, Oncology, Bone & Mineral Diseases, and Autoimmune Diseases From 2024 to 2034
Analysis of Particle-Enhanced Turbidimetric Immunoassay Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Particle-Enhanced Turbidimetric Immunoassay Market Outlook (2024 to 2034)
Worldwide revenue from the global particle-enhanced turbidimetric immunoassay market is estimated at US$ 2.03 billion in 2024. The market is further projected to increase at a CAGR of 9.6% to touch a value of US$ 5.05 billion by 2034.
Particle-enhanced turbidimetric immunoassay (PETIA) is a specialized market within the broader diagnostics and analytical testing industries. This advanced immunoassay technique offers very accurate detection of several analytics in clinical and laboratory settings by fusing the specificity and sensitivity of immunoassays with the concepts of turbidimetry.
By detecting the turbidity changes in a solution brought on by particle aggregation during antibody and antigen binding, PETIA allows for the accurate detection of several biomolecules. Because it provides a dependable and affordable substitute for more conventional detection techniques, this technology is very helpful in environmental monitoring, research, and diagnostics.
Growing consumer preference for non-invasive testing techniques and the need for quick, point-of-care diagnostics are driving the market for particle-enhanced turbidimetric immunoassay. Diagnostic instruments that deliver fast, precise findings with little sample preparation are desperately needed as the healthcare sector develops. This need is met by PETIA, which enables medical professionals to effectively identify a range of illnesses, including cancer, autoimmune disorders, infections, hormone abnormalities, and others.
One of the primary factors contributing to the increasing use of this technology is its capacity to analyze tiny sample quantities while retaining high levels of sensitivity.
Technological developments that are increasing its capabilities are helping the PETIA market grow. Continuous advancements in particle coating and reagent chemistry are one noteworthy development raising the test's sensitivity and specificity. The creation of advanced biomolecule particles, for example, greatly increases the detection limits of PETIA systems, leading to superior results in environmental monitoring and clinical diagnostics.
| Report Attribute | Detail |
|---|---|
| Particle-Enhanced Turbidimetric Immunoassay Market Size (2024E) | US$ 2.03 Billion |
| Forecasted Market Value (2034F) | US$ 5.05 Billion |
| Global Market Growth Rate (2024 to 2034) | 9.6% CAGR |
| East Asia Market Growth Rate (2024 to 2034) | 10.4% |
| North America Market Value (2034F) | US$ 1.95 Billion |
| Infectious Diseases Segment Growth Rate (2024 to 2034) | 10.2% CAGR |
| Hospitals Segment Value (2034F) | US$ 2.43 Billion |
| Key Companies Profiled | Gentian Diagnostics ASA; Eurospital; Calpro; Thermo-Fisher Scientific; Buehlmann; Biotec; Abbott Laboratories; F. Hoffmann-La Roche; Siemens AG; Danaher Corporation; Diasorin SPA; Sysmex Corporation; Biomerieux SA; QIAGEN; Agilent Technologies, Inc. |
According to the latest particle-enhanced turbidimetric immunoassay industry analysis by Fact.MR, the market is analyzed to experience significant growth from 2024 to 2034. With various research finding applications in the management of multiple diseases, this market is seeing steady growth over the forecast period of 2024 to 2034. Availability and readiness to fund innovations in the current market mark a turning point in its growth.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is driving the Demand for Particle-Enhanced Turbidimetric Immunoassay Market?
A primary driver for this market is that this technique is very swift and gives the desired reading within 10 minutes from its initiation. As mentioned in the particle-enhanced turbidimetric immunoassay industry outlook, this increases the number of samples analyzed daily.
In a comparative study conducted at Buehlmann labs, PETIA gave superior quality results with higher performance than chemiluminescent immunoassay. Making the quality of PETIA-acquired data a major player in driving the demand for this market.
Particle-enhanced turbidimetric immunoassays or PETIA is a biochemical process, which uses optical change, i.e., change in opaqueness caused by the agglutination of immunoparticles in the sample. These immunopartilcles are nothing but nanoparticles coated with antibodies. Their reaction with the taken sample makes the mixture cloudy.
A monochromatic light is then passed through the mixture to determine the opaqueness of the turbidity of the mixture. Based on the absorption of light and pre-determined calibrations as per known and standardized concentrations, quantitative measurements of body fluid components, such as proteins, pathogens, serums, urine, plasma, and others, are taken.
Another crucial driver that is driving the demand for PETIA is its flexibility, as it is integrated with any kind of chemical analyzer and quickly made a part of existing laboratory infrastructures.
PETIA & Calprotectin
A researcher at Uppsala University in Norway developed a prototype of PETIA, which holds the capability of measuring the calprotectin levels in the serum or the plasma. This technology is used in getting the calprotectin levels in inflammatory bowel disorders as this serum is called the inflammation marker for the human body. Innovative approaches, such as this to existing technologies, are driving the market in a profitable direction.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
United States and Canada Particle-Enhanced Turbidimetric Immunoassay Market
State-of-the-art research facilities and technological advancements have made the United States a most lucrative market in this field, according to the particle-enhanced turbidimetric immunoassay industry outlook. The presence of key players in the market plays a vital role in bringing novel innovation to this market.
The increasing prevalence of infectious diseases offers lucrative opportunities for the players, enabling the launch of novel immunoassay products for the timely identification of various diseases. This is estimated to drive the particle-enhanced turbidimetric immunoassay demand in the region.
Europe Particle-Enhanced Turbidimetric Immunoassay Market
The prevalence of infectious diseases and also the geriatric population is rising in Europe. According to 2019 data by Eurostat, over 90.4 million Europeans fall under the geriatric population. The innovative and novel approaches to traversing diverse applications of a single process are what make Europe the second most lucrative market. This is driving market growth.
Key players in the European region are Gentian Diagnostics ASA, Buehllman Lbs, and Roche.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Who are the Key Companies in the Particle-Enhanced Turbidimetric Immunoassay Market?
Key manufacturers and suppliers studied in the particle-enhanced turbidimetric immunoassay industry analysis are :
- Gentian Diagnostics ASA
- Eurospital
- Calpro
- Thermo-Fisher Scientific
- Buehlmann
- Biotec
- Abbott Laboratories
- F. Hoffmann-La Roche
- Siemens AG
- Danaher Corporation
- Diasorin SPA
- Sysmex Corporation
- Biomerieux SA
- QIAGEN
- Agilent Technologies, Inc.
Particle-Enhanced Turbidimetric Immunoassay Market Report Highlights :
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Segmentation of Particle-Enhanced Turbidmetric Immunoassays Market Research
-
By Application :
- Infectious Diseases
- Endocrinology
- Cardiology
- Oncology
- Bone & Mineral Diseases
- Autoimmune Diseases
- Others
-
By End User :
- Hospitals
- Academic & Research Institutions
- Pharmaceuticals & Biotechnology Companies
- Others
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Application
- 6.2. End User
- 7. Global Market Analysis and Forecast, By Application
- 7.1. Infectious Diseases
- 7.2. Endocrinology
- 7.3. Cardiology
- 7.4. Oncology
- 7.5. Bone and Mineral Diseases
- 7.6. Autoimmune Disorders
- 7.7. Others
- 8. Global Market Analysis and Forecast, By End User
- 8.1. Hospitals
- 8.2. Academic and Research Institutions
- 8.3. Pharmaceutical and Biotechnology Companies
- 8.4. Others
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Application and End User for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Gentian Diagnostics ASA
- 19.2. Eurospital
- 19.3. Calpro
- 19.4. Thermo-Fisher Scientific
- 19.5. Buehlmann
- 19.6. Biotec
- 19.7. Abbott Laboratories
- 19.8. F.Hoffmann-La Roche
- 19.9. Siemens AG
- 19.10. Danaher Corporation
- 19.11. Diasorin SPA
- 19.12. Sysmex Corporation
- 19.13. Biomerieux SA
- 19.14. QIAGEN
- 19.15. Agilent Technologies, Inc
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market US$ Mn Forecast by Region
Table 02: Global Market US$ Mn Forecast by Application
Table 03: Global Market US$ Mn Forecast by End User
Table 04: North America Market US$ Mn Forecast by Country
Table 05: North America Market US$ Mn Forecast by Application
Table 06: North America Market US$ Mn Forecast by End User
Table 07: Latin America Market US$ Mn Forecast by Country
Table 08: Latin America Market US$ Mn Forecast by Application
Table 09: Latin America Market US$ Mn Forecast by End User
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Application
Table 12: Western Europe Market US$ Mn Forecast by End User
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Application
Table 15: Eastern Europe Market US$ Mn Forecast by End User
Table 16: East Asia Market US$ Mn Forecast by Country
Table 17: East Asia Market US$ Mn Forecast by Application
Table 18: East Asia Market US$ Mn Forecast by End User
Table 19: South Asia & Pacific Market US$ Mn Forecast by Country
Table 20: South Asia & Pacific Market US$ Mn Forecast by Application
Table 21: South Asia & Pacific Market US$ Mn Forecast by End User
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Application
Table 24: MEA Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 02: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 03: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 04: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 05: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 06: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 07: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 08: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 09: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 17: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 18: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 20: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 21: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what rate is the market for particle-enhanced turbidimetric immunoassay growing?
The particle-enhanced turbidimetric immunoassay market is evaluated to rise at a 9.6% CAGR over the forecast years.
Why does the particle-enhanced turbidimetric immunoassay market have higher growth potential?
The speed of furnishing results is driving demand for these medical services.
Where are most opportunities for industry players?
The United States is estimated to be the most lucrative market for industry players.
Particle-Enhanced Turbidimetric Immunoassay Market